Selected News & Events

Stealth BioTherapeutics Receives Orphan Drug Designation from the European Medicines Agency for Elamipretide for the Treatment of Myopathic Mitochondrial DNA Depletion Syndrome

Press Release / May 31, 2022April 14, 2025

Stealth BioTherapeutics Receives Orphan Drug Designation from FDA for Elamipretide for Treatment of Duchenne Muscular Dystrophy

Press Release / May 12, 2022April 14, 2025

Stealth BioTherapeutics Announces New SBT-272 Data and Trial Initiation

Press Release / March 30, 2022April 14, 2025

Events Calendar

No events listed at this time.

@StealthBT on Twitter

StealthBT Follow

We’re driven by a desire to help those with mitochondrial dysfunction, leading mitochondrial medicine for both rare and common diseases. https://t.co/45rgM9EXLN

StealthBT @stealthbt ·

12 May

We're honored to be named one of the #XPRIZEHealthspan semifinalists! Tune into the awards livestream 5/12 at 6pm ET to learn more about the cool work @XPRIZE does & how this year’s award nominees are revolutionizing the way we think about human health. https://bit.ly/3F1chBM

Reply on Twitter 1922002420541837542 Retweet on Twitter 1922002420541837542 1 Like on Twitter 1922002420541837542 2 X 1922002420541837542

StealthBT @stealthbt ·

8 May

We're looking forward to attending @RWCRetina, where we'll share highlights from our clinical program in #dryAMD including the trial design of our P3 ReNEW and ReGAIN trials. CEO, Reenie McCarthy, will also be presenting at the Retina Unplugged session today at 9:50am ET!

Reply on Twitter 1920459083984867583 Retweet on Twitter 1920459083984867583 Like on Twitter 1920459083984867583 X 1920459083984867583

StealthBT @stealthbt ·

24 Apr

Stealth BioTherapeutics announces upcoming data presentations at the 2025 @ARVOinfo Annual Meeting. #ARVO2025

Read the full press release for more details: https://bit.ly/42MnBtB

Reply on Twitter 1915383622799937738 Retweet on Twitter 1915383622799937738 Like on Twitter 1915383622799937738 X 1915383622799937738

StealthBT @stealthbt ·

24 Apr

Attending #WODC2025? Don’t miss this conversation with CEO Reenie McCarthy and a panel of experts as they dive into the future of rare disease drug development.

Reply on Twitter 1915201009892180450 Retweet on Twitter 1915201009892180450 Like on Twitter 1915201009892180450 1 X 1915201009892180450

Contact Us

Stealth BioTherapeutics

123 Highland Ave, Suite 201
Needham, MA 02494
(617) 600-6888
info@stealthbt.com

Media Inquiries

media@stealthbt.com

Investor Inquiries

IR@stealthbt.com